🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
After screening, subjects will enter a 4 week open-label run-in period with...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10
Trial ID
NCT02119286
The study will evaluate the dose response, safety, and pharmacokinetics of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-01
Trial ID
NCT00950807
Treatments Being Tested
This is a multi-national, randomized, double-blind, 3-period crossover, inc...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-05
Trial ID
NCT01641692
Treatments Being Tested
The purpose of this 12 week study is to evaluate the effects of the additio...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01
Trial ID
NCT01772147
This is a phase III multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-03-01
Trial ID
NCT01313637
Treatments Being Tested
The purpose of this 12 week study is to evaluate the effects of the additio...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-01
Trial ID
NCT01772134
After screening, subjects will enter a 4 week open-label run-in period with...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-01
Trial ID
NCT01957163